Vycor Medical (VYCO) Shares Outstanding (Weighted Average) (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $33.4 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $33.4 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.4 million (changed 0.0% YoY), and the FY2025 annual result was $33.4 million, up 1.48% from the prior year.
• Shares Outstanding (Weighted Average) held at $33.4 million in Q1 2026 per VYCO's latest filing, from $33.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $33.4 million in Q1 2025 and troughed at $30.8 million in Q1 2022.
• A 5-year average of $32.6 million and a median of $32.6 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) increased 10.75% in 2022, then changed 0.0% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $31.7 million in 2022, then advanced by 2.82% to $32.6 million in 2023, then advanced by 0.86% to $32.9 million in 2024, then increased by 1.48% to $33.4 million in 2025, then changed by 0.0% to $33.4 million in 2026.
• Business Quant data shows VYCO's Shares Outstanding (Weighted Average) at $33.4 million in Q1 2026, $33.4 million in Q4 2025, and $33.4 million in Q3 2025.